IL297304A - הרכב לטיפול בתסמינים נשימתיים, ושיטות לשימוש בו - Google Patents

הרכב לטיפול בתסמינים נשימתיים, ושיטות לשימוש בו

Info

Publication number
IL297304A
IL297304A IL297304A IL29730422A IL297304A IL 297304 A IL297304 A IL 297304A IL 297304 A IL297304 A IL 297304A IL 29730422 A IL29730422 A IL 29730422A IL 297304 A IL297304 A IL 297304A
Authority
IL
Israel
Prior art keywords
treatment
composition
methods
respiratory symptoms
respiratory
Prior art date
Application number
IL297304A
Other languages
English (en)
Inventor
Molad Ami
Original Assignee
Molad Ami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molad Ami filed Critical Molad Ami
Publication of IL297304A publication Critical patent/IL297304A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL297304A 2020-04-14 2022-10-13 הרכב לטיפול בתסמינים נשימתיים, ושיטות לשימוש בו IL297304A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063009499P 2020-04-14 2020-04-14
PCT/IL2021/050428 WO2021209998A1 (en) 2020-04-14 2021-04-14 Composition for the treatment of respiratory symptoms and methods thereof

Publications (1)

Publication Number Publication Date
IL297304A true IL297304A (he) 2022-12-01

Family

ID=78084378

Family Applications (1)

Application Number Title Priority Date Filing Date
IL297304A IL297304A (he) 2020-04-14 2022-10-13 הרכב לטיפול בתסמינים נשימתיים, ושיטות לשימוש בו

Country Status (2)

Country Link
IL (1) IL297304A (he)
WO (1) WO2021209998A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023548863A (ja) * 2020-10-29 2023-11-21 アウラングゼーブ ナフィーズ ナギー、 テトラヒドロカンナビノールおよびそれを含む組成物を用いて急性呼吸不全および/または急性呼吸窮迫症候群を治療するための組成物および方法

Also Published As

Publication number Publication date
WO2021209998A1 (en) 2021-10-21

Similar Documents

Publication Publication Date Title
IL288061A (he) תרכובות ושיטות לטיפול ב covid-19
IL271117B (he) אימידאזופירימידינים מותמרים דיאזאביציקליים והשימוש בהם בטיפול בהפרעות נשימה
IL273388A (he) תכשירים ושיטות לטיפול ולשיפור מצבים נשימתיים ודלקת רירית
IL275678A (he) שימוש בחנקן חמצני וחמצן בשאיפה לטיפול ביתר לחץ-דם ריאתי
IL287796A (he) תכשירים ושיטות לטיפול במחלות מתווכות באמצעות atpase
IL284414A (he) שיטות ותכשירים לטיפול במחלת פברי
EP4146633A4 (en) COMPOSITION FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH APOL1
EP4171606A4 (en) COMPOSITIONS AND METHODS FOR TREATING COVID-19
EP3877383A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
EP4188346A4 (en) NOBILETIN COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COVID-19 AND RELATED DISEASES
IL283469A (he) תכשירים ניתנים לשאיפה לשימוש בטיפול במחלות ריאה
IL297304A (he) הרכב לטיפול בתסמינים נשימתיים, ושיטות לשימוש בו
PT3911347T (pt) Composição para a sua utilização no tratamento da incontinência urinária na mulher
PT3937949T (pt) Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória
EP3534713A4 (en) NON-MESENCHYMATORY HUMAN PULMONARY STEM CELLS AND METHODS OF USE THEREOF FOR TREATING RESPIRATORY DISEASES
EP4138912A4 (en) COMPOSITIONS AND METHODS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME
GB202217355D0 (en) Methods for the prophylaxis and treatment of Covid and Covid-19
IL280868A (he) תכשירים ושיטות לטיפול בפגיעה ריאתית אקוטית
SG10201902000YA (en) Isthmin 1 for treatment of lung inflammation
IL311581A (he) הרכבים ושיטות לטיפול בהפרעות הקשורות ל- pcdh19
IL314176A (he) הרכבים ושיטות לטיפול בדיכאון
IL314179A (he) הרכבים ושיטות לטיפול בדיכאון
AU2018904242A0 (en) Compounds and compositions for the treatment of respiratory diseases
AU2019901150A0 (en) Compositions and methods of treatment of respiratory tract infections
EP3846792A4 (en) METHODS AND COMPOSITIONS FOR TREATING ASTHMA OR PARKINSON'S DISEASE